The European Medicines Agency sees a connection between astrazeneca and thrombosis

The European Medicines Agency (EMA) now sees a connection between vaccinations with the corona vaccine from Astrazeneca and the occurrence of thrombosis.

Amsterdam - It is now clear that there is a "connection", said Marco Cavaleri, head of the EMA department for vaccination strategies, to the Italian newspaper Il Messaggero. What exactly is causing the reaction is not yet known, he added. The EMA announced last week that it would issue an updated recommendation for Astrazeneca at the beginning of April.

This is expected by Friday. Until recently, the authorities said that the benefits of the Astrazeneca active ingredient in the prevention of Covid-19 with the associated risk of hospitalization and death outweigh the risks of side effects.

Source: Der Newsticker

Photo: baenegocios.com